Based on CYTR's PPS movement yesterday, with a low right at .65 and a close at .795 it would have been a good decision to buy. Unfortunately, neither one of us did. I was actually expecting to see a "lower low" of .60 or less on lower volume, but it didn't happen. I'm anxious to see what CYTR does today and stand ready to act accordingly. I regret that you are unable to trade CYTR on the OTC, Rodin, as that certainly puts you at a disadvantage.
Will see what SOON has to say SOON enough (next Tuesday), although I doubt there will be anything significant relating to CYTR. We have to understand that the BIG NEWS we are anticipating still may be weeks or months off so it will be important for me to keep a close watch on CYTR's PPS over that period of time as I still have thousands of shares UP over 100%, and I'd feel very badly to see those profits quickly disappear as we did in Jul 2017.
I agree with you that Arimoclomol alone will never increase CYTR's PPS to the levels most "Longs" need to break even. IMO, only Aldox's FDA approval, manufacture and commercialization will be able to do that and MUCH MORE! My avg has increased to $1.25 with my recent sales of my lowest priced shares, but thus far, I don't regret reducing my share count just a bit. I still have thousands of shares I bought far below the current PPS that are at risk of being sold if and when the situation arises. Hopefully CYTR breaks a $1 or more this week. Will see how things go today.
All IMO. GL 2 US & CYTR!
News 
Market Data 
Discover 
